231 results on '"Moulton, Brian"'
Search Results
2. Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer
3. Analysis of Cell-Free DNA to Predict Outcome to Bevacizumab Combination Therapy in Metastatic Colorectal Cancer Patients
4. Abstract 5584: Analysis of cell free DNA to predict outcome to Bevacizumab combination therapy in metastatic colorectal cancer patients
5. Abstract P1-11-09: Five year follow up of a randomized phase II comparison of neo-adjuvant docetaxel, carboplatin, trastuzumab with or without lapatinib in HER-2 positive breast cancer
6. Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma
7. Two-step postsynthetic modifications of a dinuclear Zn(II) coordination compound: Investigating the stability of the coordination chromophore
8. Milling-Induced Disorder of Pharmaceuticals: One-Phase or Two-Phase System?
9. Postsynthetic modification of a coordination compound with a paddlewheel motif via click reaction: DOSY and ESR studies
10. Recent advances of discrete coordination complexes and coordination polymers in drug delivery
11. Save European research campaign
12. Conformational isomerism and hydrogen-bonded motifs of anion assisted supramolecular self-assemblies using Cu II/Co II salts and pyridine-4-acetamide
13. A Novel Polymorph of 5-Chloro-8-Hydroxyquinoline with Improved Water Solubility and Faster Dissolution Rate
14. Tri-metal Secondary Building Units: Toward the Design of Thermally Robust Crystalline Coordination Polymers
15. Reaction of 1,2-bis(2,6-dicarboxypyridin-4-yl)ethyne and imidazole with Cu(II) generates a discrete complex not a coordination polymer: crystal structure of [μ-4,4′-(1,2-ethynediyl)-bis(pyridine-2,6-dicarboxylato)-N, O, O′-μ-N′, O′′, O′′′]-diaqua-bis(imidazole)-dicopper(II)
16. Reaction of 1,2-bis(2,6-dicarboxypyridin-4-yl)ethyne with Co(II) generates coordination monomers not polymers: Crystal structure of 4-(2,6-dicarboxypyridin-4-yl)ethynylpyridine-2,6-dicarboxylatotriaqua cobalt(II) monohydrate
17. From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids
18. Abstract CT212: A phase III randomized study of paclitaxel (T) and trastuzumab (H) versus T, H and lapatinib (L) in first line treatment of HER2+ metastatic breast cancer (MBC)
19. Synthesis, crystal structure, and magnetic properties of binuclear Mn III-azido and 1D polymeric Mn II-μ 1,3-thiocyanato novel species based on a neutral hexadentate Schiff base
20. Two years later: the impact of the EU directive: why research in Europe has declined since the implementation of the Clinical Trials Directive
21. From molecules to crystals
22. Crystal engineering of a calix-arene dimer embedded in a hydrophobic cavity formed by a diammonium host matrix
23. Mature results of a phase I/II evaluation of docetaxel (T), ifosphamide (I), cisplatin (C) supported by lenograstim (L) in patients (pts) with advanced non-small cell lung cancer (NSCLCa): An Irish Clinical Oncology Research Group (ICORG) study.
24. Coordination polymers: toward functional transition metal sustained materials and supermolecules
25. Synthesis, crystal structure and magnetic behavior of two new binuclear complexes bridged by a pentadentate ligand: [Ni 2L 2(NCS) 2](ClO 4) 2 and [Ni 2L 2(NCO) 2](ClO 4) 2 [L=pentadentate ligand]
26. A Neutral “Molecular Railroad” Coordination Polymer That Incorporates Polycyclic Aromatic Molecules: Synthesis and Single-Crystal X-Ray Structure of [Co(4,4′bipyridine)2.5(NO3)2]·2Phenanthrene
27. Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial
28. Interpenetrating covalent and noncovalent nets in the crystal structures of [M(4,4′-bipyridine) 2(NO 3) 2]·3C 10H 8 (M = Co, Ni)
29. Additional file 2: Table S2. of Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies
30. Single-molecule magnets: a family of [Mn.sup.III]/[Ce.sup.IV] complexes with a [[Mn.sub.8]Ce[O.sub.8]](12+) core
31. Employment of 2,6-diacetylpyridine dioxime as a new route to high nuclearity metal clusters: [Mn.sub.6] and [Mn.sub.8] complexes
32. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies
33. Temporal patterns of late bowel and bladder radiotherapy toxicity in a randomised controlled trial assessing duration of neo-adjuvant hormones in prostate cancer
34. Template synthesis and single-molecule magnetism properties of a complex with spin S= 16 and a [MN8O8](super 8+) saddle-like core
35. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids
36. Supramolecular isomerism in coordination compounds: Nanoscale molecular hexagons and chains
37. Periodic tiling of pentagons: The first example of a two-dimensional (5,34)-net
38. Temporal patterns of late bowel and bladder radiotherapy toxicity in a randomised controlled trial assessing duration of neo-adjuvant hormones in prostate cancer
39. Tetranuclear [Mn2Co2], [Mn2Fe2], and [Mn2Mn2] Complexes with Defective Double‐Cubane Cores and Phenoxo and Oxo Bridges: Syntheses, Crystal Structures, and Electronic Properties
40. Phase II clinical trial of first or second-line treatment with Bortezomib in patients with malignant pleural mesothelioma
41. ICORG 06-41: A phase II trial of single-agent sorafenib in the treatment of platinum-pretreated relapsed gastroesophageal adenocarcinoma (GECa).
42. Binding of fluoro-containing anions to hexaazamacrocyclic ligand: Competitive interactions of fluoride and tetrafluoroborate anions with hexaprotonated [18]aneN6
43. Crystal Engineering of Isostructural Quaternary Multicomponent Crystal Forms of Olanzapine
44. Correction for Polymorphs, Salts and Cocrystals: What’s in a Name?
45. Serum VEGF in patients (PTS) receiving bevacizimab (BEV) for early-stage breast cancer (ESBC): ICORG 08-10.
46. Polymorphs, Salts, and Cocrystals: What’s in a Name?
47. Analysis of the GeneXpert System on the International Multicentre ICORG 08–02 Phase II Study of Nilotinib 300mg BID as Frontline Treatment in Patients with Early Chronic Phase Chronic Myeloid Leukemia (ECPCML),
48. A single-crystalline microporous coordination polymer with mixed parallel and diagonal interpenetrating α-Po networks
49. Nilotinib 300 Mg Twice Daily as First Line Treatment of Ph-Positive Chronic Myeloid Leukemia In Chronic Phase: Updated Results of the ICORG 0802 Phase 2 Study with Analysis of the GeneXpert System Versus IS BCR-ABL RQ PCR.
50. ChemInform Abstract: From Molecules to Crystal Engineering: Supramolecular Isomerism and Polymorphism in Network Solids
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.